Skip to main content
Back to Novo Holdings

Novo Holdings's Neuroscience Portfolio

Browse 4 Neuroscience companies funded by Novo Holdings. See funding amounts, founder contacts, and investment details.

Neuroscience Companies
4
Total Funding in Neuroscience
$209.8M

Neuroscience Portfolio Companies (4)

Export
BiotechnologyMental HealthNeurosciencePharmaceutical

Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.

Toronto, Canada
May 2025
$68.9M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyNeuroscience

Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.

Boston, United States
February 2025
$93.5M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsNeuroscience

Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.

Cleveland, United States
October 2025
$14.4M
Undisclosed

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsLife ScienceNeuroscience

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

Paris, France
January 2025
$32.9M
Series A

Founder Contacts

19,000+ verified contacts

Explore Novo Holdings's Full Portfolio

View all companies funded by Novo Holdings across every industry and funding stage.

View Full Novo Holdings Portfolio